Protein Therapeutics Inc.
This article was originally published in Start Up
Executive Summary
A major problem in treating rheumatoid arthritis is that current drugs cause numerous, often serious, side effects. Protein Therapeutics Inc. has developed an oral formulation of human gammaglobulin (higG) that may effectively treat rheumatoid arthritis without side effects.